How to effectively manage primary Headaches in Pregnancy?

Written By : Hina Zahid

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-01-07 11:45 GMT | Update On 2021-01-08 08:39 GMT

Effective Health Care Program has released pharmacologic and nonpharmacologic interventions to prevent or treat attacks of primary headaches (migraine, tension headache, cluster headache, and other trigeminal autonomic cephalgias) in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding.

Evidence regarding the benefits and harms of all interventions in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding is insufficient, or at best of low strength of evidence. Future research is needed to identify the most effective and safe interventions for preventing or treating primary headaches in these populations of women.of all interventions in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding is insufficient, or at best of low strength of evidence. Future research is needed to identify the most effective and safe interventions for preventing or treating primary headaches in these populations of women.

Researchers searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov to identify primary studies (comparative studies and single-group studies) in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding with primary headache (direct evidence).

Prevention of primary headache in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding with a history of primary headache
- Pharmacologic and nonpharmacologic interventions
  - There is no evidence regarding the effectiveness of any pharmacologic or nonpharmacologic intervention in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding.
  - A single primary study provided insufficient (direct) evidence to make conclusions about the harms of topiramate when used for preventing primary headache during pregnancy, but use during pregnancy outside the primary headache context (indirect evidence) suggests increased risk of fetal/child adverse effects. Indirect evidence also suggests that other antiepileptics, such as carbamazepine, gabapentin, and valproate may have similar adverse effect profiles, but lamotrigine may have a low risk of adverse effects.
  - Venlafaxine, tricyclic antidepressants (any), benzodiazepines (any), beta blockers (any), prednisolone, and oral magnesium use during pregnancy may have increased risk of fetal/child adverse effects, but calcium channel blockers (any, but nifedipine in particular) and antihistamines (any) may have a low risk of adverse effects (indirect evidence).
Treatment of patients with acute attacks of primary headache in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding
- Pharmacologic interventions
  - Use of triptans for migraine during pregnancy may not be more harmful than their use before pregnancy (both direct and systematic review evidence). Compared with nonuse (either during or before pregnancy), triptan use may not be associated with spontaneous abortions or congenital anomalies, but may be associated with worse child emotionality and activity outcomes at 3 years of age.
  - A single primary study found that compared with oral codeine, combination metoclopramide and diphenhydramine may be more effective to reduce migraine or tension headache severity during pregnancy, and may not be associated with greater serious or nonserious maternal harms; fetal/child harms were not reported. Indirect evidence found that antihistamines (any) during pregnancy (used for indications other than primary headache) may have a low risk of adverse effects.
  - Systematic reviews of harms (regardless of indication) report that acetaminophen, prednisolone, indomethacin, ondansetron, antipsychotics (any), and intravenous magnesium use during pregnancy may be associated with fetal/child adverse effects, but low-dose aspirin use may not be associated with increased risk of adverse effects.
- Nonpharmacologic interventions
  - There is insufficient direct evidence to make conclusions about the benefits or harms of acupuncture, thermal biofeedback, relaxation therapy, physical therapy, peripheral nerve blocks, and transcranial magnetic stimulation when used for treatment of primary headache during pregnancy.
  - No indirect evidence regarding harms of nonpharmacologic interventions in pregnancy was identified.

https://effectivehealthcare.ahrq.gov/products/headaches-pregnancy/research

Article Source : Agency for Healthcare Research and Quality

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Hina Zahid

Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

How to effectively manage primary Headaches in Pregnancy?

Similar News

New model predicts risk of deep vein thrombosis in patients with epithelial ovarian cancer: Study

Nitrate in drinking water linked to preterm birth rates, reports research

Good news for people with migraine who take drugs before or during pregnancy: Study

Silent Invader: Study assesses Importance of Toxoplasma Antibody Screening in Pregnancy

Hypertensive Pregnancy Disorders Linked to Long-Term Cardiovascular Risk in Women with Type 1 Diabetes: Study

Medical Bulletin 04/Jul/2025

Acupuncture significantly reduces stress, pain, and anxiety for patients undergoing IVF, suggests study

Difficult childhood experiences may increase the risk of endometriosis: Study